Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
251.75
|
|
Change (%)
|
-3.40 (-1.33%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
248.20
-
259.65
|
|
52-Week Range (RS)
|
166.20
-
277.05
|
|
Beta (1 Year)
|
1.35
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Viyash Scientific to acquire Milan-based pet care company BioForLife |
| Viyash Scientific rises after subsidiary inks Rs 188-crore deal to acquire Italy's BioForLife |
| Viyash Scientific consolidated net profit rises 459.12% in the March 2026 quarter |
| Viyash Scientific to discuss results |
| Viyash Scientific consolidated net profit declines 13.83% in the December 2025 quarter |
| Sequent Scientific to declare Quarterly Results |
|
|
|
| Incoporation Year : 1985 |
| Chairman : Kamal K Sharma |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Viyash Scientific Ltd
301 Dosti Pinnacle 3rd Floor,
Plot E7 Road No 22 Wagle Indl,
Thane,
Maharashtra-400604 |
Phone:91-022-41114777
Fax:91-022-41114754 |
| E-Mail : investors@sequent.in |
| URL : http://www.sequent.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
01-Jun-2026 |
250.50 |
0.50 |
| 1Month |
08-May-2026 |
219.00 |
14.95 |
| 3Month |
09-Mar-2026 |
190.80 |
31.94 |
| 6Month |
08-Dec-2025 |
195.65 |
28.67 |
| 1Year |
09-Jun-2025 |
189.40 |
32.92 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Quant Small Cap Fund |
1.61 |
488.82 |
| Quant Healthcare Fund |
8.62 |
30.32 |
| UTI-Healthcare Fund |
2.36 |
28.72 |
| Quant Flexi Cap Fund |
0.27 |
17.84 |
| Quant Manufacturing Fund |
2.15 |
14.36 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,788.60 |
0.28 |
1,917.15 |
1,547.25 |
429,145.05 |
| Cipla Ltd |
1,388.25 |
-0.89 |
1,672.20 |
1,165.55 |
112,149.13 |
| Zydus Lifesciences Ltd |
1,087.45 |
-0.13 |
1,115.00 |
835.85 |
109,422.92 |
| Dr Reddys Laboratories Ltd |
1,275.75 |
-0.16 |
1,377.95 |
1,149.00 |
106,482.91 |
| Lupin Ltd |
2,252.60 |
-0.68 |
2,492.00 |
1,838.65 |
102,996.20 |
|
|
|
|